Table 1.
Baseline characteristics of patients utilizing Zaitaku and hospital care
Characteristics | Zaitaku care (n = 33) |
Hospital care (n = 72) |
p-value |
---|---|---|---|
Age (mean ± SD) | 80.7 ± 12.5 | 80.2 ± 9.5 | 0.571** |
Gender | 1.000* | ||
Female (%, n) | 39.4% (n = 13) | 40.3% (n = 29) | |
Male (%, n) | 60.6% (n = 20) | 59.7% (n = 43) | |
Primary diagnosis (%, n) | |||
Cancer | 66.7% (n = 22) | 45.8% (n = 33) | 0.060* |
Dementia | 39.4% (n = 13) | 40.3% (n = 29) | 1.000* |
Oxygen (%, n) | 36.4% (n = 12) | 72.2% (n = 52) | 0.001* |
Infusion fluid (%, n) | 84.8% (n = 28) | 94.4% (n = 68) | 0.136* |
Opioids (%, n) | 42.4% (n = 14) | 40.3% (n = 29) | 0.834* |
Antibiotics (%, n) | 27.3% (n = 9) | 40.3% (n = 29) | 0.274* |
*p-values were calculated using analysis of the Fisher’s exact test
**p-value was calculated using analysis of the Wilcoxon rank sum test